White House Pulls Heidi Overton’s Nomination to Lead FDA

By Tom Gantert
Tom Gantert
Tom Gantert
Tom Gantert is a reporter for The Epoch Times.
November 17, 2026Updated: November 18, 2026

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA), it confirmed to The Epoch Times on Nov. 17.

The Senate received her nomination Sept. 14, and the Health, Education, Labor, and Pensions Committee held her confirmation hearing Sept. 24. She was nominated to succeed Martin Makary as commissioner of food and drugs.

The FDA has been without Senate-confirmed leadership since Makary resigned in May.

Sen. Bill Cassidy (R-La.), chairman of the Senate Health, Education, Labor and Pensions Committee, said Nov. 17 that the White House told him it withdrew Overton’s nomination because she lacked the votes.

“This was odd as I was having productive conversations with members,” Cassidy said in the post. “I believe she would have had the votes to pass out of committee and pass the full Senate. My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk.”

Cassidy said the administration withdrew Overton after pro-life senators sought assurances about its commitment to their priorities. With little time left in the current Congress, he said, confirming a permanent FDA commissioner will likely now fall to Senate Democrats.

In an earlier Nov. 11 post on X, Cassidy said he and other committee Republicans remained undecided on Overton’s nomination to lead the FDA and James O’Neill’s nomination to lead the National Science Foundation.

Cassidy cited distrust stemming from what he called other administration officials’ broken promises and irresponsible decisions. He said the committee was moving forward with plans to vote on both nominations, hoping to resolve their status before the current Congress ends.

Sen. Patty Murray (D-Wash.) was not supporting Overton.

“NO ONE should vote to confirm Trump’s pick for FDA Commissioner,” Murray said in a Nov. 10 post on X. “She should NOT be in charge of keeping our food and medicine safe.”

Overton, a preventive medicine physician, has served as a deputy assistant to the president for domestic policy since 2025, according to a financial disclosure posted by the White House.

When Trump announced the nomination, he called Overton a “rockstar” in his administration.

“We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES,” Trump said in the post announcing her nomination.

Americans United for Life, a pro-life legal advocacy group, had supported her nomination.

“Dr. Overton is the right candidate. She has the scientific and medical background that will enable her to perform an objective analysis of the dangers chemical abortion poses to women. Americans United for Life supports Dr. Overton as the next Commissioner of the FDA,” CEO John Mize said in a statement in August.

Kyle Diamantas has served as acting commissioner since May 15.

He previously led the agency’s Human Foods Program as deputy commissioner for food, overseeing its nutrition and food safety work. He also served as a senior counselor for the FDA at the Department of Health and Human Services beginning in February.

This is a developing story and will be updated.

Democrats Nominate Hakeem Jeffries as Next House Speaker
RELATED
California Bans Waymo Taxis From State Freeways After Accidents